HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident: Response to interferon therapy

Journal of Clinical Gastroenterology

Volumn 24, Issue 1, 1997, Pages 40-42

  Malnick, Stephen D H ^a   Abend, Yitzhak ^a   Evron, Ella ^a   Sthoeger, Zev M ^a  

^a KAPLAN HOSPITAL   (Israel)

Author keywords

Anticardiolipin antibody; Cerebrovascular accident; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON; CARDIOLIPIN ANTIBODY; LIVER ENZYME; VIRUS RNA;

ADULT; ARTICLE; BRAIN INFARCTION; CASE REPORT; CEREBROVASCULAR ACCIDENT; HEMIANOPIA; HEPATITIS C; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL;

ANTIBODIES, ANTICARDIOLIPIN; ANTIVIRAL AGENTS; CEREBRAL INFARCTION; CHRONIC DISEASE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED;

EID: 0031028562     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199701000-00009     Document Type: Article

References (13)

1. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995;123: 615-20.
2. Malnick SDH, Lurie Y, Fogel N, et al. Chronic HCV hepatitis is associated with a high incidence of anti-neutrophil cytoplasmic antibodies and anti-cardiolipin antibodies. Hepatology 1995;22:352A.
3. Matsuda J, Saitoh N, Gotoh M, et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-α. Am J Gastroenterol 1995;90:1138-41.
4. Prieto J, Juste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996;23: 1990-204.
5. Tsuboti A, Chayama K, Ikeda K, et al. Factors predictive of response to interferon-alpha therapy in hepatitis C virus infection. Hepatology 1994;19:1088-94.
6. Booth JCL, Brown JL, Thomas HC. The management of chronic hepatitis C virus infection. Gut 1995;37:449-54.
7. Geltner D, Cernik-Harush Y, Ayzenberg O. Mitral valve prolapse in young Israelis with thromboembolic brain disease. Isr J Med Sci 1991;27:5-7.
8. Drory Y, Shahar A. Mitral valve prolapse and thromboembolic brain disease. Isr J Med Sci 1991;27:44-8.
9. Cervera R, Font J, Pare C, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992;51:156-9.
10. McNeil HP, Chesterman CN, Krillis SA. Immunology and clinical importance of anti-phospholipid antibodies. Adv Immunol 1991;49: 193-280.
11. Vaarala O, Paluso T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41: 8-15.
12. Garcia-Buey L, Garcia-Monzon C, Rodriguez S, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis. Gastroenterology 1995;108:1770-7.
13. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian Registry. Am J Med 1996;100:530-6.